Information

You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

loading
Autologous Bone Marrow Transplantation for CML in Which Retroviral Markers Are Used to Discriminate Between Relapse Which Arises from Systemic Disease Remaining after Preparative Therapy Versus Relapse due to Residual Leukemia Cells in Autologous Marrow: A Pilot Trial. The University of Texas M.D. Anderson Cancer Center